Wells Fargo & Company Neuroone Medical Technologies Corp Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Neuroone Medical Technologies Corp stock. As of the latest transaction made, Wells Fargo & Company holds 333 shares of NMTC stock, worth $372. This represents 0.0% of its overall portfolio holdings.
Number of Shares
333
Previous 333
-0.0%
Holding current value
$372
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding NMTC
# of Institutions
22Shares Held
1.62MCall Options Held
40.8KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA920KShares$1.03 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA312KShares$349,0580.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il81.8KShares$91,6180.0% of portfolio
-
State Street Corp Boston, MA59.5KShares$66,6380.0% of portfolio
-
Blair William & CO Chicago, IL55.6KShares$62,2220.0% of portfolio
About NEUROONE MEDICAL TECHNOLOGIES Corp
- Ticker NMTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,209,200
- Market Cap $18.2M
- Description
- NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...